WallStreetZenWallStreetZen

NYSE: NUVB
Nuvation Bio Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for NUVB

Based on 5 analysts offering 12 month price targets for Nuvation Bio Inc.
Min Forecast
$5.00+61.29%
Avg Forecast
$6.60+112.9%
Max Forecast
$10.00+222.58%

Should I buy or sell NUVB stock?

Based on 5 analysts offering ratings for Nuvation Bio Inc.
Strong Buy
Strong Buy
2 analysts 40%
Buy
3 analysts 60%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NUVB stock forecasts and price targets.

NUVB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-24
lockedlocked$00.00+00.00%2024-05-22
lockedlocked$00.00+00.00%2024-04-17
lockedlocked$00.00+00.00%2024-03-27Find Out Why
lockedlocked$00.00+00.00%2024-03-26

1 of 1

Forecast return on equity

Is NUVB forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
27.86%

Forecast return on assets

Is NUVB forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

NUVB revenue forecast

What is NUVB's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$28.3M
Avg 2 year Forecast
$120.9M

NUVB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NUVB$3.10$6.60+112.90%Strong Buy
COGT$8.01$14.67+83.11%Buy
VRDN$11.95$30.50+155.23%Buy
STOK$14.62$21.40+46.37%Buy
NRIX$15.75$21.88+38.89%Strong Buy
View Top Biotech Stocks

Nuvation Bio Stock Forecast FAQ

Is Nuvation Bio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NYSE: NUVB) stock is to Strong Buy NUVB stock.

Out of 5 analysts, 2 (40%) are recommending NUVB as a Strong Buy, 3 (60%) are recommending NUVB as a Buy, 0 (0%) are recommending NUVB as a Hold, 0 (0%) are recommending NUVB as a Sell, and 0 (0%) are recommending NUVB as a Strong Sell.

If you're new to stock investing, here's how to buy Nuvation Bio stock.

What is NUVB's revenue growth forecast for 2026-2027?

(NYSE: NUVB) Nuvation Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.64%.

Nuvation Bio's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast NUVB's revenue for 2026 to be $6,985,042,512, with the lowest NUVB revenue forecast at $6,985,042,512, and the highest NUVB revenue forecast at $6,985,042,512.

In 2027, NUVB is forecast to generate $29,882,931,343 in revenue, with the lowest revenue forecast at $29,882,931,343 and the highest revenue forecast at $29,882,931,343.

What is NUVB's forecast return on assets (ROA) for 2024-2027?

(NYSE: NUVB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is NUVB's Price Target?

According to 5 Wall Street analysts that have issued a 1 year NUVB price target, the average NUVB price target is $6.60, with the highest NUVB stock price forecast at $10.00 and the lowest NUVB stock price forecast at $5.00.

On average, Wall Street analysts predict that Nuvation Bio's share price could reach $6.60 by May 24, 2025. The average Nuvation Bio stock price prediction forecasts a potential upside of 112.9% from the current NUVB share price of $3.10.

What is NUVB's forecast return on equity (ROE) for 2024-2027?

(NYSE: NUVB) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.